177 related articles for article (PubMed ID: 29368979)
21. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
22. Reduced
Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
[TBL] [Abstract][Full Text] [Related]
23. (1)H-MRS and MEGA-PRESS pulse sequence in the study of balance of inhibitory and excitatory neurotransmitters in the human brain of ultra-high risk of schizophrenia patients.
Menschikov PE; Semenova NA; Ublinskiy MV; Akhadov TA; Keshishyan RA; Lebedeva IS; Omelchenko MA; Kaleda VG; Varfolomeev SD
Dokl Biochem Biophys; 2016 May; 468(1):168-72. PubMed ID: 27417711
[TBL] [Abstract][Full Text] [Related]
24. Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.
Duarte JMN; Xin L
Neurochem Res; 2019 Jan; 44(1):102-116. PubMed ID: 29616444
[TBL] [Abstract][Full Text] [Related]
25. [To Test Glutamate Hypothesis for Schizophrenia Utilizing Proton Magnetic Resonance Spectroscopy].
Tsugawa S; Nakajima SL
Brain Nerve; 2017 Sep; 69(9):1035-1040. PubMed ID: 28900066
[TBL] [Abstract][Full Text] [Related]
26. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
[TBL] [Abstract][Full Text] [Related]
27. Diurnal changes in glutamate + glutamine levels of healthy young adults assessed by proton magnetic resonance spectroscopy.
Volk C; Jaramillo V; Merki R; O'Gorman Tuura R; Huber R
Hum Brain Mapp; 2018 Oct; 39(10):3984-3992. PubMed ID: 29885049
[TBL] [Abstract][Full Text] [Related]
28. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
[TBL] [Abstract][Full Text] [Related]
29. Differences in steady-state glutamate levels and variability between 'non-task-active' conditions: Evidence from
Lynn J; Woodcock EA; Anand C; Khatib D; Stanley JA
Neuroimage; 2018 May; 172():554-561. PubMed ID: 29421322
[TBL] [Abstract][Full Text] [Related]
30. Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Kubota M; Moriguchi S; Takahata K; Nakajima S; Horita N
Schizophr Res; 2020 Aug; 222():122-132. PubMed ID: 32505446
[TBL] [Abstract][Full Text] [Related]
31. Effect of L-theanine on glutamatergic function in patients with schizophrenia.
Ota M; Wakabayashi C; Sato N; Hori H; Hattori K; Teraishi T; Ozawa H; Okubo T; Kunugi H
Acta Neuropsychiatr; 2015 Oct; 27(5):291-6. PubMed ID: 25896423
[TBL] [Abstract][Full Text] [Related]
32. Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal
Cai XL; Pu CC; Zhou SZ; Wang Y; Huang J; Lui SSY; Møller A; Cheung EFC; Madsen KH; Xue R; Yu X; Chan RCK
Psychol Med; 2023 Aug; 53(11):4904-4914. PubMed ID: 35791929
[TBL] [Abstract][Full Text] [Related]
33. Human brain functional MRS reveals interplay of metabolites implicated in neurotransmission and neuroenergetics.
Koush Y; Rothman DL; Behar KL; de Graaf RA; Hyder F
J Cereb Blood Flow Metab; 2022 Jun; 42(6):911-934. PubMed ID: 35078383
[TBL] [Abstract][Full Text] [Related]
34. Functional MRS studies of GABA and glutamate/Glx - A systematic review and meta-analysis.
Pasanta D; He JL; Ford T; Oeltzschner G; Lythgoe DJ; Puts NA
Neurosci Biobehav Rev; 2023 Jan; 144():104940. PubMed ID: 36332780
[TBL] [Abstract][Full Text] [Related]
35. Glutamatergic and neural dysfunction in postpartum depression using magnetic resonance spectroscopy.
Rosa CE; Soares JC; Figueiredo FP; Cavalli RC; Barbieri MA; Schaufelberger MS; Salmon CEG; Del-Ben CM; Santos AC
Psychiatry Res Neuroimaging; 2017 Jul; 265():18-25. PubMed ID: 28494346
[TBL] [Abstract][Full Text] [Related]
36. Functional dynamics of hippocampal glutamate during associative learning assessed with in vivo
Stanley JA; Burgess A; Khatib D; Ramaseshan K; Arshad M; Wu H; Diwadkar VA
Neuroimage; 2017 Jun; 153():189-197. PubMed ID: 28363835
[TBL] [Abstract][Full Text] [Related]
37. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.
Kegeles LS; Shungu DC; Anjilvel S; Chan S; Ellis SP; Xanthopoulos E; Malaspina D; Gorman JM; Mann JJ; Laruelle M; Kaufmann CA
Psychiatry Res; 2000 May; 98(3):163-75. PubMed ID: 10821999
[TBL] [Abstract][Full Text] [Related]
38. Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Mouchlianitis E; Bloomfield MA; Law V; Beck K; Selvaraj S; Rasquinha N; Waldman A; Turkheimer FE; Egerton A; Stone J; Howes OD
Schizophr Bull; 2016 May; 42(3):744-52. PubMed ID: 26683625
[TBL] [Abstract][Full Text] [Related]
39. Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.
Ota M; Ishikawa M; Sato N; Hori H; Sasayama D; Hattori K; Teraishi T; Nakata Y; Kunugi H
Acta Psychiatr Scand; 2012 Jul; 126(1):72-8. PubMed ID: 22432602
[TBL] [Abstract][Full Text] [Related]
40. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Marsman A; van den Heuvel MP; Klomp DW; Kahn RS; Luijten PR; Hulshoff Pol HE
Schizophr Bull; 2013 Jan; 39(1):120-9. PubMed ID: 21746807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
